UNSPSC 51201814: Bropirimine

This classification denotes an immunostimulant with the molecular formula C10H8BrN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J57CTF25XJ, chemically known as 4-pyrimidinol, 2-amino-5-bromo-6-phenyl- but generally known as bropirimine, which bears US NIH Compound Identifier 65457. European Medicines Agency schedules Bropirimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05928MIG.

UNSPSC 51201814 Bropirimine is a Commodity code that covers specialized pharmaceutical agents used in immunization and disease prevention. State and local health departments procure products under this code for public health programs and vaccine distribution initiatives. The Mississippi State Department of Health is the issuing body documented in recent activity, representing state-level health administration soliciting under the code.

The most recent documented opportunity is a sole source procurement notice (3150006922, 1301-27-R-RFIN-00001) posted by the Mississippi State Department of Health on July 13, 2026, for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026 at 10:00 a.m. CST. The notice invites written objections to sole source classification with detailed explanation and supporting documentation demonstrating alternative vendor availability, directed to Cynthia Brasher at the Mississippi State Department of Health Purchasing Department. If substantiated objections are received, the department will conduct a competitive bid or selection process; if no alternative source is found, the matter escalates to the Public Procurement Review Board with burden of proof on the department. The solicitation does not specify quantity, contract term, estimated value, or pricing terms.